Showing 1 - 10 of 11
As a way of slowing COVID-19 transmission, many countries and U.S. states implemented shelter-in-place (SIP) policies. However, the effects of SIP policies on public health are a priori ambiguous as they might have unintended adverse effects on health. The effect of SIP policies on COVID-19...
Persistent link: https://www.econbiz.de/10012585414
The COVID-19 pandemic has led to a "second pandemic" of anxiety and depression. While vaccines are primarily aimed at reducing COVID-19 transmission and mortality risks, they may have important secondary benefits. We use data from U.S. Census Bureau's Household Pulse Survey merged to state-level...
Persistent link: https://www.econbiz.de/10012794620
The COVID-19 pandemic has forced federal, state and local policymakers to respond by legislating, enacting, and enforcing social distancing policies. However, the impact of these policies on healthcare utilization in the United States has been largely unexplored. We examine the impact of...
Persistent link: https://www.econbiz.de/10012482350
Persistent link: https://www.econbiz.de/10012415186
The national hepatitis C elimination initiative provides an opportunity to dramatically expand access to hepatitis C virus (HCV) treatment and put the US on a path to eliminating hepatitis C. Our objective was to project the health benefits and cost savings of this initiative. A previously...
Persistent link: https://www.econbiz.de/10014250157
Persistent link: https://www.econbiz.de/10013350386
The COVID-19 pandemic has led to a “second pandemic” of anxiety and depression. While vaccines are primarily aimed at reducing COVID-19 transmission and mortality risks, they may have important secondary benefits. We use data from U.S. Census Bureau’s Household Pulse Survey merged to...
Persistent link: https://www.econbiz.de/10013309699
The global COVID-19 vaccination campaign is the largest public health campaign in history, with over 2 billion people fully vaccinated within the first 8 months. Nevertheless, the impact of this campaign on all-cause mortality is not well understood. Leveraging the staggered rollout of vaccines,...
Persistent link: https://www.econbiz.de/10014421238
Persistent link: https://www.econbiz.de/10014370716
A long-standing economic question is how protection against harm from insurance or other harm reducing interventions leads to potentially offsetting behavior changes (ex-ante moral hazard). Immunization is a type of insurance, as individuals incur an upfront cost when they get vaccinated, but it...
Persistent link: https://www.econbiz.de/10014242381